Atlas Trials

Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis

Clinical trial NCT06592703 · RECRUITING

Trial details

NCT number
NCT06592703
Sponsor
Rennes University Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2025-03-06
Primary completion
2029-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.